
On August 6, 2026, China NIFDC publicly solicited comments on nine cosmetic standards invloving eight cosmetic ingredients and one testing method in STSC.

On August 6, 2026, China NIFDC publicly solicited comments on nine cosmetic standards invloving eight cosmetic ingredients and one testing method in STSC.

CIRS Group has compiled and summarized the latest global cosmetic regulatory developments of June 2026.

Technical Summary Based on the Latest OECD Guideline No. 497.

CIRS Group has compiled the sampling-inspection data and typical violations in June to help enterprises keep abreast of market-supervision trends and identify compliance risks.

Not all cosmetic test reports are created equal: some are rejected by regulators, and some aren’t internationally recognized. Choosing the wrong laboratory can delay your product launch or even block market entry entirely. This article explains the differences between CMA, CNAS, and ISO 17025 accreditation, why they matter for cosmetic testing in China, and how to select the right lab for regulatory compliance.

On May 29, 2026, China's STSC underwent a significant update. To accompany this update, China's NIFDC simultaneously released official supporting Q&As. CIRS Group has compiled and organized the information below for your reference.

On May 29, 2026, China’s National Medical Products Administration (NMPA) released eight testing methods to be incorporated into the corresponding chapters of the Safety and Technical Standards for Cosmetics (2015 Edition).

On February 2, 2026, the Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare, announced a revision to the annex of the Documentation Required for Case-by-Case Review of Applications for the Use of Human Cell-Derived Exosomes in Cosmetics. The revised annex takes effect immediately upon the date of announcement.

This article provides a consolidated overview of the relevant regulatory notices, supplemented by recent developments in regulatory enforcement activities-such as unannounced inspections and sampling inspections-conducted by the National Medical Products Administration (NMPA) and selected provincial and municipal authorities. The aim is to assist enterprises in staying informed of evolving regulatory trends and to reinforce awareness of quality management and compliance requirements.

On July 31, 2025, in order to further regulate and guide the research and evaluation of sunscreen cosmetics, the Cosmetic Supervision Department under China's National Medical Products Administration (NMPA) organized the National Institutes for Food and Drug Control (NIFDC) to draft two technical guidelines: the Technical Guidelines for the Research of Sunscreen Cosmetics (Trial) (Draft for Comments) and the Technical Guidelines for the Research on Quality Control Standards of Sunscreen Cosmetics (Trial) (Draft for Comments), along with their respective drafting instructions. These documents have been released to the public for consultation.